About this episode

Dr. Jeremy M. Levin discusses the value of biotechnology and the challenges facing the industry in restoring public trust.

Dr. Jeremy M. Levin is executive chairman and founder of Ovid Therapeutics. He is the author of, Biotech in the Balance: Saving a Strategic Industry in the Age of Distrust In this exclusive Schilling Show Unleashed Podcast interview, Dr. Levin discusses the value of biotechnology, strategic and financial industry challenges, and the importance of restoring public trust in medical regulatory/advisory organizations.

Explore listener stats, chart rankings, contacts and more on the The Schilling Show Unleashed Podcast podcast page.